Literature DB >> 18547618

Participation of liver cancer stem/progenitor cells in tumorigenesis of scirrhous hepatocellular carcinoma--human and cell culture study.

Takahiko Fujii1, Yoh Zen, Kenichi Harada, Hideki Niwa, Shinji Masuda, Yasuharu Kaizaki, Kishichiro Watanabe, Atsuhiro Kawashima, Yasuni Nakanuma.   

Abstract

Cancer stem cells reportedly participate in the tumorigenesis of some neoplasms. Scirrhous hepatocellular carcinoma is a variant of hepatocellular carcinoma with abundant fibrous stroma. Herein, we clinicopathologically examined scirrhous (29 cases) and conventional (50 cases) hepatocellular carcinoma with reference to cancer stem cells. Scirrhous hepatocellular carcinoma was classifiable into 3 types based on small neoplastic cells at the periphery of tumor cell nests. Of 29 cases of scirrhous hepatocellular carcinoma, 21 contained small neoplastic cells. Immunohistochemically, those cells were positive for cytokeratin 7 and ATP-binding cassette transporter G2. In 11 cases, those small tumor cells were also positive for cytokeratin 19, neural cell adhesion molecule, and epithelial cell adhesion molecule (type 1), whereas 10 cases did not show such additional expression (type 2). The remaining 8 tumors did not contain small tumor cells with stem cell features (type 3). In the central parts of tumor nests, carcinoma cells got hepatocellular markers and lost expression of neural cell adhesion molecule, and epithelial cell adhesion molecule, suggesting hepatocellular maturation. Transforming growth factor beta1, a fibrogenic cytokine, was also detected in those small tumor cells. Culture cells extracted as "side population" from hepatocellular carcinoma cell lines (HuH7 and PLC5) expressed more intensely cytokeratins 7 and 19, neural cell adhesion molecule, epithelial cell adhesion molecule, and transforming growth factor beta1 than did non-side population cells. Small tumor cells with stem cell features in scirrhous hepatocellular carcinoma may correspond to side population of culture cells and might be involved in fibrogenesis of scirrhous hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18547618     DOI: 10.1016/j.humpath.2007.12.010

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  15 in total

1.  Characterization of CD133+ parenchymal cells in the liver: histology and culture.

Authors:  Seiichi Yoshikawa; Yoh Zen; Takahiko Fujii; Yasunori Sato; Tetsuo Ohta; Yutaka Aoyagi; Yasuni Nakanuma
Journal:  World J Gastroenterol       Date:  2009-10-21       Impact factor: 5.742

Review 2.  Are hematopoietic stem cells involved in hepatocarcinogenesis?

Authors:  Antonio Facciorusso; Matteo Antonino; Valentina Del Prete; Viviana Neve; Maria Principia Scavo; Michele Barone
Journal:  Hepatobiliary Surg Nutr       Date:  2014-08       Impact factor: 7.293

3.  Postresection Outcomes of Combined Hepatocellular Carcinoma-Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.

Authors:  Young-In Yoon; Shin Hwang; Young-Joo Lee; Ki-Hun Kim; Chul-Soo Ahn; Deok-Bog Moon; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Jong-Woo Lee; Seung-Mo Hong; Eun Sil Yu; Sung-Gyu Lee
Journal:  J Gastrointest Surg       Date:  2015-12-01       Impact factor: 3.452

4.  A Convenient and Efficient Method to Enrich and Maintain Highly Proliferative Human Fetal Liver Stem Cells.

Authors:  Xuan Guo; Shu Wang; Ya-ling Dou; Xiang-fei Guo; Zhao-li Chen; Xin-wei Wang; Zhi-qiang Shen; Zhi-gang Qiu; Min Jin; Jun-wen Li
Journal:  Rejuvenation Res       Date:  2015-06-10       Impact factor: 4.663

5.  Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging.

Authors:  Seo-Youn Choi; Young Kon Kim; Ji Hye Min; Tae Wook Kang; Woo Kyoung Jeong; Soohyun Ahn; Hojeong Won
Journal:  Eur Radiol       Date:  2018-01-15       Impact factor: 5.315

Review 6.  Interpretation of interlocking key issues of cancer stem cells in malignant solid tumors.

Authors:  Wei-Hui Liu; Nan You; Ning Zhang; Hong-Tao Yan; Tao Wang; Zhu Huang; Hong-Bao Liu; Li-Jun Tang
Journal:  Cell Oncol (Dordr)       Date:  2012-11-22       Impact factor: 6.730

7.  Efficient enrichment of hepatic cancer stem-like cells from a primary rat HCC model via a density gradient centrifugation-centered method.

Authors:  Wei-hui Liu; Xing Wang; Nan You; Kai-shan Tao; Tao Wang; Li-jun Tang; Ke-feng Dou
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240

Review 8.  Cancer stem cells in primary liver cancers: pathological concepts and imaging findings.

Authors:  Ijin Joo; Haeryoung Kim; Jeong Min Lee
Journal:  Korean J Radiol       Date:  2015-01-09       Impact factor: 3.500

9.  Simple Risk Score for Prediction of Early Recurrence of Hepatocellular Carcinoma within the Milan Criteria after Orthotopic Liver Transplantation.

Authors:  Jiliang Feng; Jushan Wu; Ruidong Zhu; Dezhao Feng; Lu Yu; Yan Zhang; Dayu Bu; Chenlei Li; Yuyan Zhou; Lianghao Si; Yuhan Liu; Ziwei Liang; Jianing Xu; Tianjun Wu
Journal:  Sci Rep       Date:  2017-03-09       Impact factor: 4.379

10.  CK19 and Glypican 3 Expression Profiling in the Prognostic Indication for Patients with HCC after Surgical Resection.

Authors:  Jiliang Feng; Ruidong Zhu; Chun Chang; Lu Yu; Fang Cao; Guohua Zhu; Feng Chen; Hui Xia; Fudong Lv; Shijie Zhang; Lin Sun
Journal:  PLoS One       Date:  2016-03-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.